0000899243-18-030869.txt : 20181213 0000899243-18-030869.hdr.sgml : 20181213 20181213162722 ACCESSION NUMBER: 0000899243-18-030869 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181211 FILED AS OF DATE: 20181213 DATE AS OF CHANGE: 20181213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LANGER ROBERT CENTRAL INDEX KEY: 0001239757 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38753 FILM NUMBER: 181233527 MAIL ADDRESS: STREET 1: 98 MONTVALE RD CITY: NEWTON STATE: MA ZIP: 02459 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Moderna, Inc. CENTRAL INDEX KEY: 0001682852 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 813467528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6177146500 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: Moderna Therapeutics, Inc. DATE OF NAME CHANGE: 20160822 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-12-11 0 0001682852 Moderna, Inc. MRNA 0001239757 LANGER ROBERT C/O MODERNA, INC. 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 1 0 0 0 Common Stock 2018-12-11 4 C 0 4559 A 11466961 D Common Stock 14132 I By: Michael D. Langer Irrevocable Trust u/d/t dated 12/14/95 Common Stock 14132 I By: Samuel A. Langer Irrevocable Trust u/d/t dated 12/14/95 Common Stock 14132 I By: Susan K. Langer Irrevocable Trust u/d/t dated 12/14/95 Series G Preferred Stock 2018-12-11 4 C 0 4559 D Common Stock 4559 0 D The Series G Preferred Stock (the "Preferred Stock") converted into Common Stock based on an applicable conversion ratio of 0.45872 upon the closing of the Issuer's initial public offering on December 11, 2018. The Preferred Stock had no expiration date. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose. /s/ Jeffrey Cerio, as Attorney-in-Fact 2018-12-13